WHWK - NASDAQ

Whitehawk Therapeutics Inc

WHWK·NASDAQ

$4.18

+6.1%

HealthcareBiotechnology

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$206.71M

EPS-0.3300

P/E Ratio-7.27

Earnings Date08/06/2026

whwk

Net Cash Provided by Financing Activities

Last Annual Value

94.38M

3-Year CAGR

5-Year CAGR

140%

10-Year CAGR

28%

Adjust for Inflation

Whitehawk Therapeutics Inc Competitors Analysis of Net Cash Provided by Financing Activities

WHWK · NASDAQ

Company	Net Cash Provided by Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Whitehawk Therapeutics Inc NASDAQ:WHWK	94.38M	561.5%	-7.8%	N/A
Ovid Therapeutics Inc. NASDAQ:OVID	75.21M	35.0%	142.1%	N/A
Context Therapeutics Inc. NASDAQ:CNTX	-15.27K	N/A	N/A	N/A
Adverum Biotechnologies, Inc. NASDAQ:ADVM	120.00M	1102.6%	118.7%	71.2%
aTyr Pharma, Inc. NASDAQ:ATYR	66.01M	-0.1%	-9.7%	30.3%
Biomea Fusion, Inc. NASDAQ:BMEA	67.90M	-25.4%	-15.0%	N/A
Fractyl Health, Inc. Common Stock NASDAQ:GUTS	104.96M	56.4%	1.0%	N/A
Kalaris Therapeutics Inc NASDAQ:KLRS	159.61M	123.8%	269.4%	N/A
Oramed Pharmaceuticals Inc. NASDAQ:ORMP	-4.74M	N/A	N/A	N/A
Quince Therapeutics, Inc. NASDAQ:QNCX	-4.78M	N/A	N/A	N/A
Spruce Biosciences, Inc. NASDAQ:SPRB	43.48M	-4.0%	132.3%	N/A

Whitehawk Therapeutics Inc Fair Value Envelope

WHWK · NASDAQ

Our analysis suggests that WHWK has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.18, this represents a potential HIDDEN relative to our calculated worth for Whitehawk Therapeutics Inc.

HIDDEN

Intrinsic Value

Current Price: $4.18

Related Guides

Blog Categories

Continue your WHWK research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.